Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 45,804,000 | 33,266,000 | 32,753,000 | 28,216,000 | 25,638,000 |
| Cost of Goods | 15,387,000 | 7,439,000 | 7,718,000 | 7,042,000 | 5,832,000 |
| Gross Profit | 30,417,000 | 25,827,000 | 25,035,000 | 21,174,000 | 19,806,000 |
| Operating Expenses | 19,054,000 | 12,844,000 | 18,652,000 | 11,629,000 | 10,466,000 |
| Operating Income | 11,363,000 | 12,983,000 | 6,383,000 | 9,545,000 | 9,340,000 |
| Interest Expense | 2,280,000 | 1,509,000 | 1,144,000 | 1,004,000 | 965,000 |
| Other Income | -5,685,000 | -3,048,000 | -42,000 | -814,000 | -491,000 |
| Pre-tax Income | 3,398,000 | 8,426,000 | 5,197,000 | 7,727,000 | 7,884,000 |
| Income Tax | -1,224,000 | 544,000 | -490,000 | 2,418,000 | 1,931,000 |
| Net Income Continuous | 4,622,000 | 7,882,000 | 5,687,000 | 5,309,000 | 5,953,000 |
| Minority Interests | 6,000 | N/A | N/A | N/A | N/A |
| Net Income | $4,616,000 | $7,882,000 | $5,687,000 | $5,309,000 | $5,953,000 |
| EPS Basic Total Ops | 2.73 | 5.30 | 3.67 | 3.31 | 3.65 |
| EPS Basic Continuous Ops | 2.77 | 5.32 | 3.69 | 3.33 | 3.67 |
| EPS Diluted Total Ops | 2.72 | 5.28 | 3.66 | 3.30 | 3.63 |
| EPS Diluted Continuous Ops | 2.76 | 5.31 | 3.68 | 3.31 | 3.65 |
| EPS Diluted Before Non-Recurring Items | 10.56 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $17,834,000 | $15,000,000 | $8,148,000 | $11,046,000 | $10,529,000 |